secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001425450-24-000077
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics reports record Q2 revenue up 33% to $52.8M; net loss widens to $6.0M
--------------------------------------------------------------------------------

- Q2 2024 revenue $52.8M (+33% YoY); U.S. +39%, Intl +16%. Trauma & Deformity +37%, Scoliosis +26%.
- Net loss $6.0M ($0.26/share) vs $2.9M loss ($0.13) in Q2 2023; Adjusted EBITDA $2.6M vs $2.3M.
- Reaffirmed FY2024 revenue guidance $200M-$203M (34-36% growth); EBITDA guidance $8M-$9M.
- Announced $100M financing (term loan + convertible notes) from Braidwell LP; expects to close Aug 12, 2024.
- Approved $5M stock buyback; cash $30.9M (down from $82.3M Dec 2023) due to $5.5M one-time payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000077/0001425450-24-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000077/kids-20240805.htm
  HTML page:      https://secwatch.observer/filing/0001425450-24-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer